TABLE 1 North America Idiopathic Pulmonary Fibrosis Market, 2017 - 2020, USD Million
TABLE 2 North America Idiopathic Pulmonary Fibrosis Market, 2021 - 2027, USD Million
TABLE 3 Partnerships, Collaborations and Agreements – Idiopathic Pulmonary Fibrosis Market
TABLE 4 Approvals and Trials – Idiopathic Pulmonary Fibrosis Market
TABLE 5 Acquisition and Mergers – Idiopathic Pulmonary Fibrosis Market
TABLE 6 North America Idiopathic Pulmonary Fibrosis Market by Drug Type, 2017 - 2020, USD Million
TABLE 7 North America Idiopathic Pulmonary Fibrosis Market by Drug Type, 2021 - 2027, USD Million
TABLE 8 North America Pirfenidone Market by Country, 2017 - 2020, USD Million
TABLE 9 North America Pirfenidone Market by Country, 2021 - 2027, USD Million
TABLE 10 North America Nintedanib Market by Country, 2017 - 2020, USD Million
TABLE 11 North America Nintedanib Market by Country, 2021 - 2027, USD Million
TABLE 12 North America Idiopathic Pulmonary Fibrosis Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 13 North America Idiopathic Pulmonary Fibrosis Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 14 North America Retail Pharmacies Market by Country, 2017 - 2020, USD Million
TABLE 15 North America Retail Pharmacies Market by Country, 2021 - 2027, USD Million
TABLE 16 North America Hospital Pharmacies Market by Country, 2017 - 2020, USD Million
TABLE 17 North America Hospital Pharmacies Market by Country, 2021 - 2027, USD Million
TABLE 18 North America Online Providers Market by Country, 2017 - 2020, USD Million
TABLE 19 North America Online Providers Market by Country, 2021 - 2027, USD Million
TABLE 20 North America Idiopathic Pulmonary Fibrosis Market by Country, 2017 - 2020, USD Million
TABLE 21 North America Idiopathic Pulmonary Fibrosis Market by Country, 2021 - 2027, USD Million
TABLE 22 US Idiopathic Pulmonary Fibrosis Market, 2017 - 2020, USD Million
TABLE 23 US Idiopathic Pulmonary Fibrosis Market, 2021 - 2027, USD Million
TABLE 24 US Idiopathic Pulmonary Fibrosis Market by Drug Type, 2017 - 2020, USD Million
TABLE 25 US Idiopathic Pulmonary Fibrosis Market by Drug Type, 2021 - 2027, USD Million
TABLE 26 US Idiopathic Pulmonary Fibrosis Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 27 US Idiopathic Pulmonary Fibrosis Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 28 Canada Idiopathic Pulmonary Fibrosis Market, 2017 - 2020, USD Million
TABLE 29 Canada Idiopathic Pulmonary Fibrosis Market, 2021 - 2027, USD Million
TABLE 30 Canada Idiopathic Pulmonary Fibrosis Market by Drug Type, 2017 - 2020, USD Million
TABLE 31 Canada Idiopathic Pulmonary Fibrosis Market by Drug Type, 2021 - 2027, USD Million
TABLE 32 Canada Idiopathic Pulmonary Fibrosis Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 33 Canada Idiopathic Pulmonary Fibrosis Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 34 Mexico Idiopathic Pulmonary Fibrosis Market, 2017 - 2020, USD Million
TABLE 35 Mexico Idiopathic Pulmonary Fibrosis Market, 2021 - 2027, USD Million
TABLE 36 Mexico Idiopathic Pulmonary Fibrosis Market by Drug Type, 2017 - 2020, USD Million
TABLE 37 Mexico Idiopathic Pulmonary Fibrosis Market by Drug Type, 2021 - 2027, USD Million
TABLE 38 Mexico Idiopathic Pulmonary Fibrosis Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 39 Mexico Idiopathic Pulmonary Fibrosis Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 40 Rest of North America Idiopathic Pulmonary Fibrosis Market, 2017 - 2020, USD Million
TABLE 41 Rest of North America Idiopathic Pulmonary Fibrosis Market, 2021 - 2027, USD Million
TABLE 42 Rest of North America Idiopathic Pulmonary Fibrosis Market by Drug Type, 2017 - 2020, USD Million
TABLE 43 Rest of North America Idiopathic Pulmonary Fibrosis Market by Drug Type, 2021 - 2027, USD Million
TABLE 44 Rest of North America Idiopathic Pulmonary Fibrosis Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 45 Rest of North America Idiopathic Pulmonary Fibrosis Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 46 Key Information – GNI Group Ltd.
TABLE 47 Key Information – Shionogi & Co., Ltd.
TABLE 48 Key Information – Mission Therapeutics Ltd.
TABLE 49 Key Information – Galapagos NV
TABLE 50 Key Information – FibroGen, Inc.
TABLE 51 Key Information – AstraZeneca PLC
TABLE 52 key information – F. Hoffmann-La Roche Ltd.
TABLE 53 Key Information – Bristol Myers Squibb Company
TABLE 54 Key Information – Boehringer Ingelheim International GmbH
TABLE 55 Key Information – Biogen, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2017-2021)
FIG 4 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2017, Apr – 2021, Dec) Leading Players
FIG 5 Recent strategies and developments: F. Hoffmann-La Roche Ltd.
Unique Offerings 